Skip to main content
. 2018 Apr 4;42(1):45–52. doi: 10.1007/s40618-018-0882-4

Table 1.

Patients’ characteristics

Characteristic Patients with DTC and CLT
n = 331
Patients with DTC and without CLT
n = 576
P value OR (Odds ratio) with 95% CI (confidence interval)
Female/Male, n (%) 312/19 (94/6) 489/87 (85/15) < 0.0001 2.92 (1.74–4.90)
Median age at diagnosis, years (range) 45 (18–79) 50 (18–84) < 0.0001
Multifocality, n (%) 68 (20.5) 89 (15.5) 0.0557 1.41 (1.00–2.01)
Capsule invasion, n (%) 66 (19.9) 83 (14.4) 0.033 1.48 (1.04–2.11)
Extracapsular invasion, n (%) 55 (16.6) 143 (24.8) 0.004 0.60 (0.43–0.85)
Nodal (N) involvement, n (%) 32 (9.7) 81 (14.1) 0.048 0.65 (0.42–0.99)
Mean tumour size, mm (range) 15.7 (1–250) 12.1 (1–95) 0.618
Tumour diameter ≤ 10 mm, n (%) 180 (54.4) 305 (53.0) 0.285 1.06 (0.81–1.39)
Papillary thyroid carcinoma, n (%) 307 (92.7) 530 (92.0) 0.796 1.11 (0.66–1.85)
 Classical, n (%) 233 (70.4) 414 (71.9) 0.703 0.93 (0.69–1.25)
 Follicular, n (%) 50 (15.1) 80 (13.9) 0.694 1.10 (0.75–1.62)
 Classical/follicular, n (%) 11 (3.3) 19 (3.3) 1.000 1.01 (0.47–2.14)
 Oxyphilic, n (%) 9 (2.7) 15 (2.6) 1.000 1.05 (0.45–2.42)
 Follicular/oxyphilic, n (%) 4 (1.2) 2 (0.3) 0.199 3.51 (0.64–19.27)
Follicular thyroid carcinoma, n (%) 24 (7.3) 46 (8.0) 0.796 0.90 (0.54–1.50)
 Classical, n (%) 16 (4.9) 34 (5.9) 0.583 0.71 (0.24–2.07)
 Oncocytic (Hürthle cell) variant, n (%) 8 (2.4) 12 (2.1)

Italics represents statistically significant values